EADO/WCM 2025 | Refining follow-up strategies to address overdiagnosis in early-stage melanoma

Iris Zalaudek • 3 Apr 2025

EADO/WCM 2025

Melanoma Skin Cancer

Iris Zalaudek, MD, PhD, University of Trieste, Trieste, Italy, discusses the challenge of overdiagnosis in early-stage melanoma and the need for a more refined follow-up strategy. Current guidelines recommend biannual follow-ups for patients with stage 1A melanoma in the first five years, followed by annual visits. However, with rising patient numbers and limited dermatology resources, risk-based assessments are essential to identify those needing lifelong surveillance. Prof. Zalaudek highlights a study from Florence identifying clinical features of thin melanomas prone to metastasis, which may guide tailored follow-up strategies. This interview took place at the 11th World Congress of Melanoma and 21st EADO Congress in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.